Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH sets sights on $323m more for Alzheimer's

This article was originally published in Scrip

Executive Summary

If Dr Francis Collins, director of the National Institutes of Health (NIH) had just $323m more in his agency's purse, it could do so much more to advance research into Alzheimer's disease, he said in a special funding request, known as a "bypass budget," which was transmitted directly to President Barack Obama, who will subsequently send it on to Congress, without having to go through the normal White House request channels.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC029359

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel